Sale!

SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC34A1 gene plays a crucial role in phosphate transport in the kidneys, and mutations in this gene can lead to Fanconi Renotubular Syndrome Type 2 (FRTS2). This condition is characterized by impaired kidney function, leading to issues with mineral and electrolyte balance. The genetic test for the SLC34A1 gene mutation is a critical tool in diagnosing FRTS2, enabling healthcare providers to tailor treatment and management strategies for affected individuals.

At DNA Labs UAE, the genetic test for the SLC34A1 mutation associated with Fanconi Renotubular Syndrome Type 2 is available. The cost of the test is 4400 AED. This test is conducted using advanced genetic sequencing technologies to accurately identify mutations in the SLC34A1 gene. By opting for this test, patients and their families can gain valuable insights into their genetic predisposition to FRTS2, allowing for early intervention and better management of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test

Genetic testing plays a crucial role in diagnosing and managing various genetic disorders. One such disorder is Fanconi Renotubular Syndrome Type 2, which is associated with the SLC34A1 gene. This syndrome is characterized by impaired reabsorption of phosphate by the kidneys, leading to excessive phosphate excretion in the urine.

Test Details

The SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test is a comprehensive genetic test that analyzes the SLC34A1 gene using Next-Generation Sequencing (NGS) technology. This test helps in identifying genetic variations or mutations that may be causing the disorder.

Components

  • Test Name: SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology Nephrology Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected by the disorder.

Importance of NGS Genetic Testing

NGS genetic testing allows for the simultaneous analysis of multiple genes, enabling the identification of genetic variations or mutations associated with specific disorders. In the case of Fanconi Renotubular Syndrome Type 2, NGS genetic testing helps in identifying variations or mutations in the SLC34A1 gene, aiding in accurate diagnosis and appropriate treatment and management strategies.

It is important to note that NGS genetic testing may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Furthermore, genetic testing should always be conducted under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and support.

Test Name SLC34A1 Gene Fanconi renotubular syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC34A1 Gene Fanconi renotubular syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC34A1 Gene Fanconi renotubular syndrome type 2 NGS Genetic DNA Test gene SLC34A1
Test Details

The SLC34A1 gene is associated with Fanconi renotubular syndrome type 2, also known as renal phosphate wasting disorder. This genetic disorder is characterized by impaired reabsorption of phosphate by the kidneys, leading to excessive phosphate excretion in the urine.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a specific disorder or condition. In the case of Fanconi renotubular syndrome type 2, NGS genetic testing can be used to identify variations or mutations in the SLC34A1 gene that may be causing the disorder.

NGS testing involves sequencing the DNA of an individual and comparing it to a reference genome to identify any differences or mutations. This can help healthcare providers make an accurate diagnosis and provide appropriate treatment and management strategies for individuals with Fanconi renotubular syndrome type 2.

It is important to note that NGS genetic testing may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Additionally, genetic testing should always be conducted under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and support.